Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma (NCT03374007) | Genor Biopharma Co., Ltd. | 2017-10-19 |
| Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT03077828) | Northwestern University | 2017-04-21 |
Track Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.